Mereo BioPharma Group plc (MPH.L) (MPH) News Today GBX 26.50 -0.50 (-1.85%) (As of 12/17/2020) Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Mereo BioPharma Group plcSeptember 5, 2024 | thestreet.comBuy Rating Affirmed for Mereo Biopharma on Strong Clinical and Financial ProspectsAugust 15, 2024 | markets.businessinsider.comMereo BioPharma Group plc (MAH0.F)July 19, 2024 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Mereo Biopharma Group Plc (MREO), GoodRx Holdings (GDRX) and NewAmsterdam Pharma Company (NAMS)May 20, 2024 | markets.businessinsider.comMereo BioPharma Group PLC ADR MREOApril 14, 2024 | morningstar.comMereo BioPharma Group plc - Depositary Receipt () (MREO) Price Target Increased by 17.65% to 5.10February 24, 2024 | msn.comMereo BioPharma Group Stock (NASDAQ:MREO), Insider Trading ActivityFebruary 23, 2024 | benzinga.comMereo BioPharma Group PLC ADRFebruary 22, 2024 | wsj.comMereo BioPharma provides update on pipeline progress, reaffirms cash runway guidanceJanuary 8, 2024 | msn.comBTIG Keeps Their Buy Rating on Mereo Biopharma Group Plc (MREO)January 8, 2024 | markets.businessinsider.comMereo BioPharma Provides Update on Pipeline Progress and Corporate DevelopmentsJanuary 8, 2024 | markets.businessinsider.comMereo BioPharma: Lagging Stock Despite Positive DataDecember 13, 2023 | seekingalpha.comMereo BioPharma Reports on Recent Program Developments and Provides Financial UpdateOctober 23, 2023 | markets.businessinsider.comSVB Securities Sticks to Its Buy Rating for Mereo Biopharma Group Plc (MREO)June 14, 2023 | markets.businessinsider.comUltragenyx, Mereo shares gain after positive results from study of bone disorder treatmentJune 6, 2023 | msn.comUltragenyx, Mereo gain on Phase 2 data for bone disorder therapyJune 6, 2023 | msn.comMereo BioPharma to Present at the Jefferies Healthcare ConferenceMay 31, 2023 | technews.tmcnet.comNavigating Mereo BioPharma's Future: Risky Proposition Despite Strides In Rare Disease TreatmentMay 29, 2023 | msn.comMereo BioPharma transfers ADS listing from Nasdaq Global Market to Nasdaq Capital MarketMay 5, 2023 | msn.comMereo BioPharma Announces Listing Transfer to Nasdaq Capital MarketMay 5, 2023 | technews.tmcnet.comMereo BioPharma Reports Full Year 2022 Financial Results and Recent HighlightsMarch 28, 2023 | benzinga.comMereo soars ~25% after FDA, EMA guidance on main goals of trial for lung disease drugMarch 21, 2023 | msn.comShort Volatility Alert: Mereo BiopharmaDecember 21, 2022 | benzinga.comMereo BioPharma Reaches Cooperation Agreement with Rubric Capital ManagementOctober 28, 2022 | technews.tmcnet.comMereo BioPharma Gets FDA Fast-Track Designation for Alvelestat >MREOOctober 17, 2022 | marketwatch.comMereo BioPharma: FDA Grants Fast Track Designation For Alvelestat - Quick FactsOctober 17, 2022 | markets.businessinsider.comRubric Capital Management Increases Slate of Proposed Mereo BioPharmaDirector Nominees to FiveOctober 5, 2022 | marketwatch.comMereo BioPharma Offered to Settle Proxy Contest with Rubric Capital Management by Putting Rubric Principal and Second New Director on the BoardSeptember 26, 2022 | benzinga.comMereo BioPharma: An Activist Pressure With A Potentially Significant UpsideSeptember 22, 2022 | seekingalpha.comTitus Welliver Joins Titans Season 4 as Lex Luthor, November Premiere SetSeptember 13, 2022 | yahoo.comMereo cites 'deficiencies' in investor Rubric's letter seeking general meeting, removal of directorsAugust 23, 2022 | seekingalpha.comMereo BioPharma Regains Compliance with Nasdaq Minimum Bid Price RequirementJuly 5, 2022 | finance.yahoo.comWhy Mereo BioPharma Shares Are Jumping TodayJune 17, 2022 | finance.yahoo.comMereo BioPharma: Activist Pressure In A Net-Net BiopharmaJune 17, 2022 | seekingalpha.comAlliance Pharma To Acquire LGC's Bio-analytical Business Arm For Undisclosed SumMay 17, 2022 | markets.businessinsider.comARTRYA SIGNS FIRST U.S. HOSPITAL CLINICAL PARTNERSHIP WITH HUNTSVILLE HEART CENTERMay 11, 2022 | finance.yahoo.comNew Research Continues to Reinforce Effectiveness of Massage Therapy for Relief of Chronic PainMay 11, 2022 | finance.yahoo.comMereo BioPharma to Host Conferene Call Highlighting Top-line Clinical Data from "ASTRAEUS" Phase 2 Study of AlvelestatMay 7, 2022 | tmcnet.com Get Mereo BioPharma Group plc (MPH.L) News Delivered to You Automatically Sign up to receive the latest news and ratings for MPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Election warning coming true… (Ad)If you missed it, my emergency election broadcast is now available - watch it before it's too late. Click here to watch it now. MPH Media Mentions By Week MPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MPH News Sentiment▼0.000.46▲Average Medical News Sentiment MPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MPH Articles This Week▼00▲MPH Articles Average Week Get Mereo BioPharma Group plc (MPH.L) News Delivered to You Automatically Sign up to receive the latest news and ratings for MPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AVCT News BVXP News HVO News FARN News ARIX News SCLP News FUM News REDX News ETX News POLB News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:MPH) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mereo BioPharma Group plc (MPH.L) Please log in to your account or sign up in order to add this asset to your watchlist. Share Mereo BioPharma Group plc (MPH.L) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
